News

VA106483 Phase IIb trial for nocturia

2 February 2010

Vantia Therapeutics' lead candidate VA106483 enters Phase IIb trial for nocturia more »

VA111913 Phase II trial in dysmenorrhoea

6 October 2009

Vantia Therapeutics' lead candidate VA111913 enters Phase II POC trial in dysmenorrhoea more »

Contact Details

vantia_building


Vantia Therapeutics

Southampton Science Park
1 Venture Road
Chilworth
Southampton
SO16 7NP
United Kingdom
t +44 23 8076 3400
f +44 23 8076 6755
http://www.vantia.com
info@vantia.com


Business Development:
For enquiries about partnering programs with Vantia Therapeutics please contact bus.dev@vantia.com.